Atlas Trials

Intralesional Injection of Metronidazole for the Management of Cutaneous Leishmaniasis

Clinical trial NCT06798415 · RECRUITING

Trial details

NCT number
NCT06798415
Sponsor
Hayder Adnan Fawzi
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Cutaneous Leishmaniasis
Start date
2025-02-10
Primary completion
2025-05-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.